The right not to know and preimplantation genetic diagnosis for Huntington's disease.
The right not to know is underappreciated in policy-making. Despite its articulation in medical law and ethics, policy-makers too easily let other concerns override the right not to know. This observation is triggered by a recent decision of the Dutch government on embryo selection for Huntington's disease. This is a monogenetic debilitating disease without cure, leading to death in early middle age, and thus is a likely candidate for preimplantation genetic diagnosis (PGD). People possibly affected with the Huntington gene do not always want to know their genetic status themselves, which is very burdensome knowledge. For prospective parents, this creates a difficulty in having unaffected children through embryo selection without knowing their own genetic status. A solution is provided by the exclusion test: it allows embryo selection while honouring the parents' right not to know. The Dutch government however disallowed the exclusion test and chose to allow PGD on Huntington only for parents who test themselves first. To avoid "unnecessary" in-vitro fertilisation procedures for unaffected parents, prospective parents are "forced to know" before they can conceive through embryo selection. This article analyses the scope of the right not to know in the context of embryo selection against Huntington's disease. It concludes that the right not to know implies that PGD against Huntington should be allowed by means of the exclusion test.
Asscher
E
E
Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands. e.asscher@erasmusmc.nl
Koops
B-J
BJ
D003219:Confidentiality; D004624:Embryo Transfer; D004992:Ethics, Medical; D005260:Female; D005817:Genetic Counseling / Q000941:ethics*; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis* / Q000235:genetics*; D011247:Pregnancy; D019836:Preimplantation Diagnosis